The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Open accessAbstract
Diabetic nephropathy (DN) is a progressive kidney disease, a well-known complication of long-standing diabetes. DN is the most frequent reason for dialysis in many Western countries. Early detection may enable development of specific drugs and early initiation of therapy, thereby postponing/preventing the need for renal replacement therapy. We evaluated urinary proteome analysis as a tool for prediction of DN. Capillary electrophoresis–coupled mass spectrometry was used to profile the low–molecular weight proteome in urine. We examined urine samples from a longitudinal cohort of type 1 and 2 diabetic patients (n = 35) using a previously generated chronic kidney disease (CKD) biomarker classifier to assess peptides of collected urines for signs of DN. The application of this classifier to samples of normoalbuminuric subjects up to 5 years prior to development of macroalbuminuria enabled early detection of subsequent progression to macroalbuminuria (area under the curve [AUC] 0.93) compared with urinary albumin routinely used to determine the diagnosis (AUC 0.67). Statistical analysis of each urinary CKD biomarker depicted its regulation with respect to diagnosis of DN over time. Collagen fragments were prominent biomarkers 3–5 years before onset of macroalbuminuria. Before albumin excretion starts to increase, there is a decrease in collagen fragments. Urinary proteomics enables noninvasive assessment of DN risk at an early stage via determination of specific collagen fragments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
Good, D. M., Zürbig, P., Argilés, À., Bauer, H. W., Behrens, G., Coon, J. J., Dakna, M., Decramer, S., Delles, C., Dominiczak, A. F., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001917 · Cited by 524
Self-citationBrenner, B. M., Cooper, M. E., & de Zeeuw, D. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00549-9 · Cited by 508
Parving, H.-H., Hommel, E., Mathiesen, E., Skott, P., Edsberg, B., Bahnsen, M., Lauritzen, M., Hougaard, P., & Lauritzen, E. (1988) · BMJ · doi:10.1136/bmj.296.6616.156 · Cited by 448
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
Caramori, M. L., Fioretto, P., & Mauer, M. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1399 · Cited by 434
Hovind, P., Tarnow, L., Rossing, P., Graae, M., Torp, I., Binder, C., & Parving, H.-H. (2004) · BMJ · doi:10.1136/bmj.38070.450891.fe · Cited by 432
Self-citationDiscovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis
Theodorescu, D., Wittke, S., Ross, M. M., Walden, M., Conaway, M., Just, I., Mischak, H., & Frierson, H. F. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70584-8 · Cited by 410
Self-citationCurrent issues in measurement and reporting of urinary albumin excretion
Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.106567 · Cited by 381
Kolch, W., Neusüß, C., Pelzing, M., & Mischak, H. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20051 · Cited by 290
Self-citationPerkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010) · Kidney International · doi:10.1038/ki.2009.399 · Cited by 289
Advances in Urinary Proteome Analysis and Biomarker Discovery
Fliser, D., Novak, J., Thongboonkerd, V., Argile[Combining Acute Accent]s, A. G. A., Jankowski, V., Girolami, M. A., Jankowski, J., & Mischak, H. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090956 · Cited by 286
Self-citationUrinary Proteomics in Diabetes and CKD
Rossing, K., Mischak, H., Dakna, M., Zürbig, P., Novak, J., Julian, B. A., Good, D. M., Coon, J. J., Tarnow, L., & Rossing, P. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091025 · Cited by 283
Self-citationDecramer, S., Wittke, S., Mischak, H., Zürbig, P., Walden, M., Bouissou, F., Bascands, J.-L., & Schanstra, J. P. (2006) · Nature Medicine · doi:10.1038/nm1384 · Cited by 274
Self-citationQuantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., & Metzger, J. (2009) · Journal of Proteome Research · doi:10.1021/pr800401m · Cited by 259
Self-citationBilous, R., Chaturvedi, N., Sjølie, A. K., Fuller, J., Klein, R., Orchard, T., Porta, M., & Parving, H.-H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00120 · Cited by 252
Good, D. M., Thongboonkerd, V., Novak, J., Bascands, J.-L., Schanstra, J. P., Coon, J. J., Dominiczak, A., & Mischak, H. (2007) · Journal of Proteome Research · doi:10.1021/pr070529w · Cited by 244
Self-citationCheng, S., Pollock, A. S., Mahimkar, R., Olson, J. L., Lovett, D. H., Cheng, S., Pollock, A. S., Mahimkar, R., Olson, J. L., & Lovert, D. H. (2006) · The FASEB Journal · doi:10.1096/fj.06-5898fje · Cited by 223
DeLeo, J. M. (2002) · 1993 (2nd) International Symposium on Uncertainty Modeling and Analysis · doi:10.1109/isuma.1993.366750 · Cited by 213
CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F., Decramer, S., Fliser, D., Frommberger, M., Golovko, I., Good, D. M., Herget‐Rosenthal, S., et al. (2008) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200800024 · Cited by 207
Self-citationNeuhoff, N. V., Kaiser, T., Wittke, S., Krebs, R., Pitt, A., Burchard, A., Sundmacher, A., Schlegelberger, B., Kolch, W., & Mischak, H. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1294 · Cited by 200
Self-citationPrevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes: The BENEDICT Study
Remuzzi, G., Macia, M., & Ruggenenti, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121324 · Cited by 194
Mischak, H., Coon, J. J., Novak, J., Weissinger, E. M., Schanstra, J. P., & Dominiczak, A. F. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20205 · Cited by 193
Self-citationZürbig, P., Renfrow, M. B., Schiffer, E., Novak, J., Walden, M., Wittke, S., Just, I., Pelzing, M., Neusüß, C., Theodorescu, D., et al. (2006) · ELECTROPHORESIS · doi:10.1002/elps.200500827 · Cited by 193
Self-citationWittke, S., Fliser, D., Haubitz, M., Bartel, S., Krebs, R., Hausadel, F., Hillmann, M., Golovko, I., Koester, P., Haller, H., et al. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00713-1 · Cited by 191
Self-citationDiabetic kidney disease with and without albuminuria
MacIsaac, R. J., & Jerums, G. (2011) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e3283456546 · Cited by 189
Self-citationThe global burden of chronic kidney disease and the way forward.
Alebiosu, C. O., & Ayodele, O. E. (2005) · PubMed · Cited by 179
Mischak, H., Kölch, W., Aivaliotis, M., Bouyssié, D., Court, M., Dihazi, H., Dihazi, G. H., Franke, J., Garin, J., de Peredo, A. G., et al. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900189 · Cited by 156
Self-citationUrinary biomarkers involved in type 2 diabetes: a review
Matheson, A., Willcox, M. D. P., Flanagan, J., & Walsh, B. J. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1068 · Cited by 151
Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy
Alkhalaf, A., Zürbig, P., Bakker, S. J. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013421 · Cited by 134
Self-citationHuman urinary peptide database for multiple disease biomarker discovery
Siwy, J., Mullen, W., Golovko, I., Franke, J., & Zürbig, P. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000155 · Cited by 117
Self-citationHaubitz, M., Good, D. M., Woywodt, A., Haller, H. G., Rupprecht, H., Theodorescu, D., Dakna, M., Coon, J. J., & Mischak, H. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800529-mcp200 · Cited by 111
Self-citationKistler, A. D., Mischak, H., Poster, D., Dakna, M., Wuthrich, R. P., & Serra, A. L. (2009) · Kidney International · doi:10.1038/ki.2009.93 · Cited by 98
Self-citationPrediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005
Rossing, P. R. (2005) · Diabetologia · doi:10.1007/s00125-005-0077-3 · Cited by 94
Self-citationHidaka, S., Kränzlin, B., Gretz, N., & Witzgall, R. (2002) · Cell and Tissue Research · doi:10.1007/s00441-002-0629-5 · Cited by 89
Bio-support vector machines for computational proteomics
Yang, Z. R., & Chou, K. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg477 · Cited by 87
Andersen, S., Mischak, H., Zürbig, P., Parving, H., & Rossing, P. R. (2010) · BMC Nephrology · doi:10.1186/1471-2369-11-29 · Cited by 84
Self-citationElectrophoretic methods for analysis of urinary polypeptides in IgA‐associated renal diseases
Julian, B. A., Wittke, S., Novák, J., Good, D. M., Coon, J. J., Kellmann, M., Zürbig, P., Schiffer, E., Haubitz, M., Moldoveanu, Z., et al. (2007) · Electrophoresis · doi:10.1002/elps.200700237 · Cited by 82
Self-citationMischak, H., Delles, C., Klein, J., & Schanstra, J. P. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.09.004 · Cited by 79
Self-citationRossing, K., Mischak, H., Rossing, P. R., Schanstra, J. P., Wiseman, A. C., & Maahs, D. M. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780166 · Cited by 70
Self-citationDepletion of clusterin in renal diseases causing nephrotic syndrome
Ghiggeri, G. M., Bruschi, M., Candiano, G., Rastaldi, M. P., Scolari, F., Passerini, P., Musante, L., Pertica, N., Caridi, G., Ferrario, F., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00664.x · Cited by 64
New and old markers of progression of diabetic nephropathy
Jerums, G., Premaratne, E., Panagiotopoulos, S., Clarke, S., Power, D. A., & MacIsaac, R. J. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.032 · Cited by 63
Self-citationThe natural progression of kidney injury in young type 1 diabetic patients
Steinke, J. M. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0077-7 · Cited by 21
Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk?
Aronis, K. N., Kim, Y., & Mantzoros, C. S. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.013 · Cited by 13
Cited by
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
Self-citationDiagnosis of diabetic kidney disease: state of the art and future perspective
Persson, F., & Rossing, P. (2018) · Kidney International Supplements · doi:10.1016/j.kisu.2017.10.003 · Cited by 335
Self-citationQuantitative variability of 342 plasma proteins in a human twin population
Liu, Y., Buil, A., Collins, B. C., Gillet, L. C., Blum, L. C., Cheng, L., Vitek, O., Mouritsen, J., Lachance, G., Spector, T. D., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145728 · Cited by 328
Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
Rysz, J., Gluba-Brzózka, A., Franczyk, B., Jabłonowski, Z., & Ciałkowska-Rysz, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081702 · Cited by 278
Biomarkers of diabetic kidney disease
Colhoun, H. M., & Marcovecchio, M. L. (2018) · Diabetologia · doi:10.1007/s00125-018-4567-5 · Cited by 270
Metadata
- Authors
- Zürbig, P., Jerums, G., Hovind, P., MacIsaac, R. J., Mischak, H., Nielsen, S. E., Panagiotopoulos, S., Persson, F., & Rossing, P.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-11-15
- Volume
- 61
- Issue
- 12
- Pages
- 3304-3313
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2099000521
- Cited by
- 266
- References
- 47
- FWCI
- 20.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.